For decades, cancer immunotherapy has focused primarily on CD8+ cytotoxic T lymphocytes as the main executors of tumor cell ...
A new scientific review highlights how disruptions in the timing and behaviour of immune cells may hold the key to understanding ...
CD4+ T cells, long regarded as supporting actors in cancer immunity, are emerging as central regulators of tumor control and ...
Methods developed and validated to establish the “World Bank of NK Cells” from healthy donors and cancer patientsSingle ...
Why eczema is so common in infancy has remained a persistent mystery, with studies hampered by ethics concerns surrounding infant skin biopsies. A fragile skin barrier is the most commonly accepted ...
Independent Data Monitoring Committee Recommends Discontinuation of Phase III Trial Following Futility AnalysisSYDNEY, AUSTRALIA, March 13, 2026 ...
Type 1 diabetes (T1D) is an autoimmune disease characterized by the immune-mediated destruction of pancreatic B cells. While autoreactive T cells are key ...
Cancer immunotherapy has transformed oncology, yet many patients fail to respond or eventually develop resistance. Emerging research reveals that the ...
Independent Data Monitoring Committee Recommends Discontinuation of Phase III Trial Following Futility Analysis SYDNEY, AUSTRALIA, March 13, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: ...
The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical ...
Cancer immunotherapy has transformed oncology, yet many patients fail to respond or eventually develop resistance.
A multi-disciplinary research team at the Wyss Institute at Harvard University, Dana-Farber Cancer Institute, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results